跳至主要内容
临床试验/NCT02083107
NCT02083107已完成2 期

COMPARISON BETWEEN RECTAL & SUBLINGUAL MISOPROSTOL BEFORE CAESARIAN SECTION TO REDUCE INTRA & POST-OPERATIVE BLOOD LOSS

Ain Shams University1 个研究点 分布在 1 个国家目标入组 636 人开始时间: 2013年2月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
636
试验地点
1
主要终点
Intraoperative Blood Loss

研究概览

简要总结

The aim of the work is to evaluate & compare the effectiveness of rectally administered PGE1 synthetic analogue (misoprostol) 400 microgram versus sublingually administered misoprostol before caesarean section to decrease blood loss during and after the operation.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
18 Years 至 38 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Patients booked for elective cesarean section.
  • Singleton pregnancies. 3- Full term pregnancies (GA 37-42 weeks). 4- Patients with only previous one cesarian section

排除标准

  • Primigravida.
  • Blood dyscrasias.
  • Large fibroids.
  • Multiple pregnancies.
  • Overdistended uterus eg. Hydramnios.
  • Pre-eclampsia.
  • Marked maternal anemia (Preoperative hemoglobin < 9 gm/dl).
  • Previous history of PPH.
  • Contraindications to prostaglandin therapy (e.g. history of severe bronchial asthma or allergy to misoprostol.
  • Placenta previa.
  • Contraindication to spinal anesthesia.
  • Previous myomectomy.
  • Previous two or more C.S.

研究组 & 干预措施

sublingual misoprostol & rectal placebo

Experimental

will receive 400 microgram of misoprostol (Sigma) sublingual "2 tablets" and rectal placebo"2 tablets".

干预措施: Misoprostol (Drug)

rectal & sublingual placebo

Placebo Comparator

will receive rectal placebo"2 tablets" and sublingual placebo"2 tablets".

干预措施: Placebo (Other)

rectal misoprostol & sublingual placebo

Experimental

will receive 400 microgram of misoprostol (Sigma) rectal "2 tablets" and sublingual placebo"2 tablets".

干预措施: Misoprostol (Drug)

结局指标

主要结局

Intraoperative Blood Loss

时间窗: from start of cesarean section till the end of operation (average one hour)

次要结局

  • Incidence of Adverse Effects(24 hours)
  • Need for Extra Analgesics(average 24 hours)
  • Need for Extra Ecbolics (Oxytocin).(from start of cesarean section till the end of operation (average one hour))
  • APGAR Score(1minute and 5 minutes from delivery of the fetus)
  • Time to Resume Bowel Habits(average 24 hours)
  • Need for Postoperative Blood Transfusion(average 24 hours)
  • Incidence of Wound Sepsis(upto one week)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mohamed S Sweed, MD

Mohamed S. Sweed, Lecturer of Obstetrics &Gynecology, Ain Shams University

Ain Shams University

研究点 (1)

Loading locations...

相似试验